Ono Pharmaceutical Co., Ltd.
$5.07+1.00%(+$0.05)
TickerSpark Score
95/100
93
Valuation
90
Profitability
90
Growth
100
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OPHLY research report →
52-Week Range72% of range
Low $3.35
Current $5.07
High $5.75
Companywww.ono-pharma.com
Ono Pharmaceutical Co. , Ltd. , together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
- CEO
- Gyo Sagara
- IPO
- 2012
- Employees
- 3,853
- HQ
- Osaka, JP
Price Chart
+50.45% · this period
Valuation
- Market Cap
- $7.15B
- P/E
- 16.68
- P/S
- 2.25
- P/B
- 1.37
- EV/EBITDA
- 7.41
- Div Yield
- 3.24%
Profitability
- Gross Margin
- 72.52%
- Op Margin
- 20.03%
- Net Margin
- 13.53%
- ROE
- 8.54%
- ROIC
- 7.95%
Growth & Income
- Revenue
- $546.89B · 12.33%
- Net Income
- $73.97B · 47.81%
- EPS
- $52.73 · 48.46%
- Op Income
- $109.57B
- FCF YoY
- 86.23%
Performance & Tape
- 52W High
- $5.75
- 52W Low
- $3.35
- 50D MA
- $5.06
- 200D MA
- $4.56
- Beta
- 0.11
- Avg Volume
- 30.72K
Get TickerSpark's AI analysis on OPHLY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our OPHLY Coverage
We haven't published any research on OPHLY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate OPHLY Report →Similar Companies
HLBBF+0.00%
H. Lundbeck A/S
$7.16
GZPHF+0.00%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
$2.34
HKMPF+0.00%
Hikma Pharmaceuticals PLC
$19.10
HKMPY+0.00%
Hikma Pharmaceuticals PLC
$39.20
SNPHF+0.00%
Santen Pharmaceutical Co., Ltd.
$10.99
HLUBF+0.00%
H. Lundbeck A/S
$5.50
KYKOF+0.00%
Kyowa Kirin Co., Ltd.
$14.43
DSRLF+0.00%
DiaSorin S.p.A.
$67.00